These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27542570)

  • 1. Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders.
    Ghosh A; Chen F; Thakur A; Hong H
    CNS Neurosci Ther; 2016 Dec; 22(12):943-951. PubMed ID: 27542570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.
    Gelosa P; Colazzo F; Tremoli E; Sironi L; Castiglioni L
    Mediators Inflamm; 2017; 2017():3454212. PubMed ID: 28607533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease.
    Rahman SO; Singh RK; Hussain S; Akhtar M; Najmi AK
    Eur J Pharmacol; 2019 Jan; 842():208-220. PubMed ID: 30389631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
    Singh RK; Gupta S; Dastidar S; Ray A
    Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cysteinyl leukotrienes in patients with rhinitis, sinusitis and paranasal polyps.
    Parnes SM
    Am J Respir Med; 2002; 1(6):403-8. PubMed ID: 14720027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders.
    Jo-Watanabe A; Okuno T; Yokomizo T
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of leukotrienes in allergic diseases.
    Liu M; Yokomizo T
    Allergol Int; 2015 Jan; 64(1):17-26. PubMed ID: 25572555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending the understanding of leukotrienes in asthma.
    Coffey M; Peters-Golden M
    Curr Opin Allergy Clin Immunol; 2003 Feb; 3(1):57-63. PubMed ID: 12582316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer's disease.
    Chen F; Ghosh A; Lin J; Zhang C; Pan Y; Thakur A; Singh K; Hong H; Tang S
    Brain Behav Immun; 2020 Aug; 88():844-855. PubMed ID: 32222525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
    Sharma JN; Mohammed LA
    Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids.
    Rubin P; Mollison KW
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):188-97. PubMed ID: 17481554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis.
    Peters-Golden M; Gleason MM; Togias A
    Clin Exp Allergy; 2006 Jun; 36(6):689-703. PubMed ID: 16776669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modulation of leukotriene pathway - potential targets].
    Peter H; Lýdia B
    Ceska Slov Farm; 2012 Jun; 61(3):101-6. PubMed ID: 22913825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cysteinyl leukotrienes: where do they come from? What are they? Where are they going?
    Austen KF
    Nat Immunol; 2008 Feb; 9(2):113-5. PubMed ID: 18204420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: Signaling through the CysLT₂ receptor.
    Capra V; Carnini C; Accomazzo MR; Di Gennaro A; Fiumicelli M; Borroni E; Brivio I; Buccellati C; Mangano P; Carnevali S; Rovati G; Sala A
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():115-25. PubMed ID: 25839425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene signaling in neurodegeneration: implications for treatment strategies.
    Sharma V; Sharma P; Singh TG
    Inflammopharmacology; 2024 Dec; 32(6):3571-3584. PubMed ID: 39167313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of cysteinyl leukotrienes in chronic inflammation and neoplasia of the intestine].
    Broom OJ; Nielsen OH
    Ugeskr Laeger; 2009 Jan; 171(4):243-6. PubMed ID: 19174041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases.
    Colazzo F; Gelosa P; Tremoli E; Sironi L; Castiglioni L
    Mediators Inflamm; 2017; 2017():2432958. PubMed ID: 28932020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional functions for the cysteinyl leukotrienes recognized through studies of inflammatory processes in null strains.
    Austen KF
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):182-7. PubMed ID: 17481553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding to cysteinyl-leukotriene receptors.
    Nicosia S; Capra V; Ravasi S; Rovati GE
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S46-50. PubMed ID: 10673226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.